Tesofensine (500 mcg) is a compound being investigated for its potential role in regulating appetite and promoting fat loss. As a monoamine reuptake inhibitor, Tesofensine works by inhibiting the reuptake of dopamine, norepinephrine, and serotonin, which may influence metabolic processes and energy balance.
While initially researched for its effects on Parkinson’s disease and Alzheimer’s disease, Tesofensine has gained attention for its potential as an anti-obesity agent in clinical trials. It is important to note that Tesofensine is intended for research purposes only.
Research Purposes only
100 tablets
